Hence, recognizing the role of particular factors, including those secreted by tumor cells, and understanding the pathways responsible for endothelial transdifferentiation in the promotion of CAFs behavior, represents a very attractive target in the search for new effective anti-cancer therapies. Here, TBX1 is linked to neoplasm.